Nutex Health Inc. Short Report by Capybara Research
Title: Problems at Nutex, Part One: Booted From Over a Dozen ERs As Founder/CEO Accused of Fraud, Embezzlement, and Self-Dealing
Published 2025-11-25 Short Seller: Capybara Research
Performance since publication
Nutex Health Inc. (NUTX)
| Benchmark (T-1 close) | Intraday low | End of day | Current Price | Stock Return | Thesis P&L |
|---|---|---|---|---|---|
| $137.21 | -22.0% | -12.5% | $160.95 | +17.3% | -17.3% |
NUTX Short Report Impact
Intraday (5‑minute) on 2025-11-25
Daily closes since report
From 2025-11-24 (day before report) through 2025-12-05.
Publication details
Published Nov 25, 2025 10:26:06 AM ESTTweet announcing reportOriginal report
Related reports
- HydroGraph: A $1Bn Graphene 'Science Project' Propped up by Paid Stock Promotion with No Path to Commercialization, Misrepresented Regulatory Approval, Unscalable Tech, and Failed Partnerships — Capybara Research
- Quantum Deception: A $2 Billion fraud built on fake products, fake revenue, and fake partnerships — Capybara Research
- Richtech Robotics: A China Hustle Selling Rebranded Chinese Robots, Plus Insider Embezzlement, Fake Partnerships, Fake Deals, Fabricated WalMart Hype, Undisclosed Related Party Transactions, and Links to China Scam Stocks — Capybara Research
- A Fake Acquisition to Prop up a Conman's Crumbling Empire — Capybara Research